Literature DB >> 28078237

Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model.

Delphine Behr-Roussel1, François Giuliano2.   

Abstract

Entities:  

Year:  2016        PMID: 28078237      PMCID: PMC5182213          DOI: 10.21037/tau.2016.11.07

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


× No keyword cloud information.
Currently available pharmacological erectile dysfunction (ED) treatments improve erectile function when impaired, yet none are curative. The search for a disease-modifying treatment for ED is the goal of this coming decade, with the advent of promising therapeutic strategies such as gene therapy and stem cell regeneration, while attempts for rehabilitation treatment protocols in men with ED using chronic phosphodiesterase-5-inhibitors (PDE5-Is) i.e., after radical prostatectomy have failed. However, data on the therapeutic benefits of these treatments to restore erectile function are still scarce. Pioneer clinical studies reporting the use of low-intensity extracorporeal shock wave therapy (Li-ESWT) have shown that Li-ESWT could improve erectile function and penile hemodynamics in men with ED who respond to pharmacotherapy and convert PDE5-I non-responders to responders (1-4). More clinical studies have been conducted since then revealing encouraging results, such as the improvement of International Index of Erectile Function score and/or Erectile Hardness Score and an effect that lasts up to 1 year (5-10). Therefore, it seems that Li-ESWT has the potential to become the first non-invasive curative treatment for ED patients (11-13). These exciting clinical proof-of-concept studies trigger many questions, among which the mechanism of action of Li-ESWT responsible for this beneficial effect on erectile function. To date, however, very few preclinical studies have been led to investigate these aspects (14-16). Of note, all these studies report positive effects of Li-ESWT on erectile function whatever the experimental ED model used. Moreover, several hypotheses for Li-ESWT’s mechanisms of action in erectile function recovery have been inspired by previous studies conducted in other basic science fields. It was thus shown that Li-ESWT triggers the activation of various intracellular signaling pathways causing upregulation of numerous angiogenic factors (i.e., VEGF…) to promote neovascularization and mobilizes the recruitment of endogenous progenitor cells thereby favoring angiogenesis and tissue regeneration in cardiovascular medicine and wound healing (17-21). These pro-angiogenic signaling pathways and recruitment of endogenous progenitor cells have also been shown to be activated in the penile tissue following Li-ESWT treatment in diabetic ED models (15,16), despite the fact that it does not upregulate the NO/cGMP pathway (14). Moreover, the role of Li-ESWT in the regeneration of peripheral nerves has also been previously suggested after nerve compression or in a model of autologous nerve graft (22,23) and later investigated in the context of erectile function recovery in diabetic ED models (15,16). In this study (24), Tom Lue and his colleagues investigated the effects of two different treatment regimen using Li-ESWT (low energy: 0.06 mJ/mm2, 300 pulses, 3 Hz during 4 weeks and 1 week wash-out or high energy: 0.09 mJ/mm2, 1,000 pulses, 3 Hz during 4 weeks and 1 week wash-out) in a new experimental model of neurovascular ED produced by both bilateral cavernous nerve injury (CNI) and internal pudendal bundle (IPB) injury. This model is meant to mimic trauma-related ED that “commonly occurs in the setting of pelvic surgery or as a result of local injuries such as improvised explosive device in battlefield […]”. Patients suffering from this form of ED are often not responsive to standard of care such as PDE5-Is and represent difficult-to-treat patients. In this study, Li-ESWT at both “low energy” and “high energy” is successful at improving erectile response to cavernous nerve stimulation. Demonstration of penile angiogenesis, tissue restoration, and penile nerve regeneration including nNOS-positive nerve fibers coinciding with recruitment of endogenous progenitor cells to the damaged area was obtained. Moreover, both dedifferentiation and proliferation of Schwann cells at the site of pelvic injury was evidenced, further supporting the concept of nerve regeneration. Shock waves are acoustic waves characterized by high pressure amplitudes and an abrupt increase in pressure in comparison to the ambient pressure. There are various medical devices delivering shock waves, using various techniques [Radial pressure wave (RSWT), electrohydraulic, electromagnetic or piezoelectric shockwave] and equipped with a focused, soft-focused and/or unfocused reflector depending on the indication and the tissue that shall be treated. Thus, these technologies differ in the manner in which the shockwaves are produced, the ability of the shockwave to be controlled and focused, the depth to which the shockwaves can penetrate, and the overall amount of energy being produced. Therefore, results obtained in a study with a specific device/protocol do not allow for extrapolation on different devices or setups. It is particularly the case when investigating Li-ESWT in a preclinical setting, since particular care is needed to adapt the equipment to the size of the experimental model used. Thus, care to reduce the loss of energy between the shockwave electrode and the targeted tissue is mandatory. Intensity, duration of each session and total number of sessions may need to be determined according to the kind of equipment, and it is of paramount importance that measurement of the actual amount of energy delivered to the targeted site is performed, in order to mimic as closely as possible the amount of energy which is delivered to patients. In this study, it is inferred that these treatments were applied once a week although this information was not provided. Moreover, the focused shockwave source was delivered to the “pelvic region” of the rat. Has the actual amount of energy been measured on the targeted site and how does this setting compare to the delivery of Li-ESWT to the penile shaft of ED patients receiving Li-ESWT treatment? In any case, it should be emphasized that such experimental studies on the use of Li-ESWT are very rare and time-consuming. As such, these data are a very valuable contribution in the understanding of the mechanistic actions of Li-ESWT in an experimental setting of ED. Thus, Li and co-workers (24) should be both congratulated for this work and encouraged to pursue this line of much-needed basic science research.
  24 in total

1.  Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy.

Authors:  Stephen R Zins; Mihret F Amare; Douglas K Tadaki; Eric A Elster; Thomas A Davis
Journal:  Angiogenesis       Date:  2010-09-17       Impact factor: 9.596

2.  Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy.

Authors:  Ilan Gruenwald; Boaz Appel; Yoram Vardi
Journal:  J Sex Med       Date:  2011-10-18       Impact factor: 3.802

3.  Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial.

Authors:  Eric Chung; Ross Cartmill
Journal:  BJU Int       Date:  2015-04       Impact factor: 5.588

Review 4.  Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis.

Authors:  Zhihua Lu; Guiting Lin; Amanda Reed-Maldonado; Chunxi Wang; Yung-Chin Lee; Tom F Lue
Journal:  Eur Urol       Date:  2016-06-16       Impact factor: 20.096

5.  Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia.

Authors:  Alexandra Aicher; Christopher Heeschen; Ken-ichiro Sasaki; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2006-12-04       Impact factor: 29.690

6.  Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo.

Authors:  Takahiro Nishida; Hiroaki Shimokawa; Keiji Oi; Hideki Tatewaki; Toyokazu Uwatoku; Kohtaro Abe; Yasuharu Matsumoto; Noriyoshi Kajihara; Masataka Eto; Takehisa Matsuda; Hisataka Yasui; Akira Takeshita; Kenji Sunagawa
Journal:  Circulation       Date:  2004-11-01       Impact factor: 29.690

7.  Shock wave treatment improves nerve regeneration in the rat.

Authors:  Siegfried Mense; Ulrich Hoheisel
Journal:  Muscle Nerve       Date:  2013-03-16       Impact factor: 3.217

8.  Improved rate of peripheral nerve regeneration induced by extracorporeal shock wave treatment in the rat.

Authors:  Thomas Hausner; Krisztián Pajer; Gabriel Halat; Rudolf Hopf; Robert Schmidhammer; Heinz Redl; Antal Nógrádi
Journal:  Exp Neurol       Date:  2012-05-01       Impact factor: 5.330

9.  Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction.

Authors:  A Ruffo; M Capece; D Prezioso; G Romeo; E Illiano; L Romis; G Di Lauro; F Iacono
Journal:  Int Braz J Urol       Date:  2015 Sep-Oct       Impact factor: 1.541

10.  Evaluation of the effect of different doses of low energy shock wave therapy on the erectile function of streptozotocin (STZ)-induced diabetic rats.

Authors:  Jing Liu; Feng Zhou; Guang-Yong Li; Lin Wang; Hui-Xi Li; Guang-Yi Bai; Rui-Li Guan; Yong-De Xu; Ze-Zhu Gao; Wen-Jie Tian; Zhong-Cheng Xin
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

View more
  9 in total

Review 1.  The Basic Physics of Waves, Soundwaves, and Shockwaves for Erectile Dysfunction.

Authors:  Jonathan Elliott Katz; Raul Ivan Clavijo; Paul Rizk; Ranjith Ramasamy
Journal:  Sex Med Rev       Date:  2019-11-14

2.  Low-intensity extracorporeal shockwave therapy ameliorates diabetic underactive bladder in streptozotocin-induced diabetic rats.

Authors:  Hsun Shuan Wang; Byung Seok Oh; Bohan Wang; Yajun Ruan; Jun Zhou; Lia Banie; Yung Chin Lee; Arianna Tamaddon; Tie Zhou; Guifang Wang; Guiting Lin; Tom F Lue
Journal:  BJU Int       Date:  2018-04-20       Impact factor: 5.588

Review 3.  Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA).

Authors:  James L Liu; Kevin Y Chu; Andrew T Gabrielson; Run Wang; Landon Trost; Gregory Broderick; Kelvin Davies; Gerald Brock; John Mulhall; Ranjith Ramasamy; Trinity J Bivalacqua
Journal:  Sex Med       Date:  2021-05-14       Impact factor: 2.491

4.  Effect of Linear Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction-12-Month Follow-Up of a Randomized, Double-Blinded, Sham-Controlled Study.

Authors:  Grzegorz Lukasz Fojecki; Stefan Tiessen; Palle Jørn Sloth Osther
Journal:  Sex Med       Date:  2017-12-21       Impact factor: 2.491

Review 5.  Role and mechanism of micro-energy treatment in regenerative medicine.

Authors:  Yegang Chen; Qiliang Cai; Jiancheng Pan; Dingrong Zhang; Jiang Wang; Ruili Guan; Wenjie Tian; Hongen Lei; Yuanjie Niu; Yinglu Guo; Changyi Quan; Zhongcheng Xin
Journal:  Transl Androl Urol       Date:  2020-04

6.  Combined treatment with extracorporeal shockwaves therapy and an herbal formulation for activation of penile progenitor cells and antioxidant activity in diabetic erectile dysfunction.

Authors:  Seung Hwan Jeon; Woong Jin Bae; Guan Qun Zhu; Wenjie Tian; Eun Bi Kwon; Ga Eun Kim; Sung Yeoun Hwang; Kyu Won Lee; Hyuk Jin Cho; U-Syn Ha; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim
Journal:  Transl Androl Urol       Date:  2020-04

Review 7.  Extracorporeal shock wave therapy versus local corticosteroid injection for the treatment of carpal tunnel syndrome: a meta-analysis.

Authors:  Wenhao Li; Chunke Dong; Hongyu Wei; Zhencheng Xiong; Liubo Zhang; Jun Zhou; Yanlei Wang; Jipeng Song; Mingsheng Tan
Journal:  J Orthop Surg Res       Date:  2020-11-23       Impact factor: 2.359

Review 8.  New Frontiers of Extracorporeal Shock Wave Medicine in Urology from Bench to Clinical Studies.

Authors:  Po-Yen Chen; Jai-Hong Cheng; Zong-Sheng Wu; Yao-Chi Chuang
Journal:  Biomedicines       Date:  2022-03-15

9.  Extracorporeal shock wave therapy combined with engineered mesenchymal stem cells expressing stromal cell-derived factor-1 can improve erectile dysfunction in streptozotocin-induced diabetic rats.

Authors:  Dongho Shin; Seung Hwan Jeon; Wen Jie Tian; Eun Bi Kwon; Ga Eun Kim; Woong Jin Bae; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim
Journal:  Transl Androl Urol       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.